How much revenue does Biostar Pharmaceuticals make?

Biostar Pharmaceuticals reported $2.38 million in revenue for fiscal year 2016, down 91.2% from $27.13 million in fiscal year 2015. In Q3 2017 revenue was $0.

What companies are similar to Biostar Pharmaceuticals?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Nabriva Therapeutics plc (NBRVF), Plant-Based Investment Corp. (CWWBF), Targeted Medical Pharma, Inc. (TRGM), ForU Holdings, Inc. (FORU).

Biostar Pharmaceuticals, Inc. (BSPM) Stock

About Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides OTC products, such as Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common c...

At a glance

Biostar Pharmaceuticals reported revenue of $2.38 million for fiscal year 2016, down 91.2% from fiscal year 2015, and net income of -$5.70 million. In Q3 2017 (the quarter ended September 30, 2017) revenue was $0, down 100.0% from a year before.

Figures from company filings; latest fiscal year ended December 31, 2016.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.